Private Advisor Group’s Calidi Biotherapeutics CLDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,875
Closed -$5.1K – 3216
2026
Q2
$5.1K Buy
+1,875
New +$6.06K ﹤0.01% 2510

Other funds holding CLDI

Private Advisor Group's CLDI Position: Q3 2026 in Review

Private Advisor Group sold out of Calidi Biotherapeutics (CLDI) in Q3 2026, closing a stake of 1,875 shares — an estimated $5.1K sold.

Private Advisor Group first reported a position in CLDI in Q2 2026 and held it in 1 quarter. The position peaked at $5.1K in Q2 2026. 20 funds tracked by Wall St. Rank hold CLDI as of Q3 2026.

  • Private Advisor Group reported no remaining Calidi Biotherapeutics position as of Q3 2026 after selling out during the quarter.
  • Private Advisor Group sold 1,875 Calidi Biotherapeutics shares in Q3 2026, an estimated $5.1K.
  • Private Advisor Group first reported a position in Calidi Biotherapeutics in Q2 2026 and held it in 1 quarter.
  • Private Advisor Group's Calidi Biotherapeutics position peaked at $5.1K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.